229 related articles for article (PubMed ID: 32193252)
1. C-FGF23 peptide alleviates hypoferremia during acute inflammation.
Agoro R; Park MY; Le Henaff C; Jankauskas S; Gaias A; Chen G; Mohammadi M; Sitara D
Haematologica; 2021 Feb; 106(2):391-403. PubMed ID: 32193252
[TBL] [Abstract][Full Text] [Related]
2. Bone-derived C-terminal FGF23 cleaved peptides increase iron availability in acute inflammation.
Courbon G; Thomas JJ; Martinez-Calle M; Wang X; Spindler J; Von Drasek J; Hunt-Tobey B; Mehta R; Isakova T; Chang W; Creemers JWM; Ji P; Martin A; David V
Blood; 2023 Jul; 142(1):106-118. PubMed ID: 37053547
[TBL] [Abstract][Full Text] [Related]
3. Analysis of IL-22 contribution to hepcidin induction and hypoferremia during the response to LPS in vivo.
Wallace DF; Subramaniam VN
Int Immunol; 2015 Jun; 27(6):281-7. PubMed ID: 25568302
[TBL] [Abstract][Full Text] [Related]
4. A novel inflammatory pathway mediating rapid hepcidin-independent hypoferremia.
Guida C; Altamura S; Klein FA; Galy B; Boutros M; Ulmer AJ; Hentze MW; Muckenthaler MU
Blood; 2015 Apr; 125(14):2265-75. PubMed ID: 25662334
[TBL] [Abstract][Full Text] [Related]
5. Role of hepcidin in the setting of hypoferremia during acute inflammation.
Deschemin JC; Vaulont S
PLoS One; 2013; 8(4):e61050. PubMed ID: 23637785
[TBL] [Abstract][Full Text] [Related]
6. Inflammation-induced up-regulation of hepcidin and down-regulation of ferroportin transcription are dependent on macrophage polarization.
Agoro R; Mura C
Blood Cells Mol Dis; 2016 Oct; 61():16-25. PubMed ID: 27667162
[TBL] [Abstract][Full Text] [Related]
7. Toll-like receptor signal adaptor protein MyD88 is required for sustained endotoxin-induced acute hypoferremic response in mice.
Layoun A; Huang H; Calvé A; Santos MM
Am J Pathol; 2012 Jun; 180(6):2340-50. PubMed ID: 22497726
[TBL] [Abstract][Full Text] [Related]
8. Hepcidin inhibition improves iron homeostasis in ferrous sulfate and LPS treatment model in mice.
Patel V; Joharapurkar A; Kshirsagar S; Patel M; Patel H; Savsani H; Jain M
Drug Res (Stuttg); 2021 Nov; 71(9):528-534. PubMed ID: 34311475
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological inhibition of prolyl hydroxylase protects against inflammation-induced anemia via efficient erythropoiesis and hepcidin downregulation.
Jain M; Joharapurkar A; Patel V; Kshirsagar S; Sutariya B; Patel M; Patel H; Patel PR
Eur J Pharmacol; 2019 Jan; 843():113-120. PubMed ID: 30458168
[TBL] [Abstract][Full Text] [Related]
10. A crosstalk between hepcidin and IRE/IRP pathways controls ferroportin expression and determines serum iron levels in mice.
Charlebois E; Fillebeen C; Katsarou A; Rabinovich A; Wisniewski K; Venkataramani V; Michalke B; Velentza A; Pantopoulos K
Elife; 2022 Sep; 11():. PubMed ID: 36066082
[TBL] [Abstract][Full Text] [Related]
11. Hepcidin-Mediated Hypoferremia Disrupts Immune Responses to Vaccination and Infection.
Frost JN; Tan TK; Abbas M; Wideman SK; Bonadonna M; Stoffel NU; Wray K; Kronsteiner B; Smits G; Campagna DR; Duarte TL; Lopes JM; Shah A; Armitage AE; Arezes J; Lim PJ; Preston AE; Ahern D; Teh M; Naylor C; Salio M; Gileadi U; Andrews SC; Dunachie SJ; Zimmermann MB; van der Klis FRM; Cerundolo V; Bannard O; Draper SJ; Townsend ARM; Galy B; Fleming MD; Lewis MC; Drakesmith H
Med; 2021 Feb; 2(2):164-179.e12. PubMed ID: 33665641
[TBL] [Abstract][Full Text] [Related]
12. Late stage erythroid precursor production is impaired in mice with chronic inflammation.
Prince OD; Langdon JM; Layman AJ; Prince IC; Sabogal M; Mak HH; Berger AE; Cheadle C; Chrest FJ; Yu Q; Andrews NC; Xue QL; Civin CI; Walston JD; Roy CN
Haematologica; 2012 Nov; 97(11):1648-56. PubMed ID: 22581006
[TBL] [Abstract][Full Text] [Related]
13. Vitamin A deficiency modulates iron metabolism via ineffective erythropoiesis.
da Cunha MS; Siqueira EM; Trindade LS; Arruda SF
J Nutr Biochem; 2014 Oct; 25(10):1035-44. PubMed ID: 24998947
[TBL] [Abstract][Full Text] [Related]
14. EPO-dependent induction of erythroferrone drives hepcidin suppression and systematic iron absorption under phenylhydrazine-induced hemolytic anemia.
Jiang X; Gao M; Chen Y; Liu J; Qi S; Ma J; Zhang Z; Xu Y
Blood Cells Mol Dis; 2016 May; 58():45-51. PubMed ID: 27067488
[TBL] [Abstract][Full Text] [Related]
15. Smad1/5 is required for erythropoietin-mediated suppression of hepcidin in mice.
Wang CY; Core AB; Canali S; Zumbrennen-Bullough KB; Ozer S; Umans L; Zwijsen A; Babitt JL
Blood; 2017 Jul; 130(1):73-83. PubMed ID: 28438754
[TBL] [Abstract][Full Text] [Related]
16. Circulating iron levels influence the regulation of hepcidin following stimulated erythropoiesis.
Mirciov CSG; Wilkins SJ; Hung GCC; Helman SL; Anderson GJ; Frazer DM
Haematologica; 2018 Oct; 103(10):1616-1626. PubMed ID: 29903760
[TBL] [Abstract][Full Text] [Related]
17. Hepcidin mediates hypoferremia and reduces the growth potential of bacteria in the immediate post-natal period in human neonates.
Prentice S; Jallow AT; Sinjanka E; Jallow MW; Sise EA; Kessler NJ; Wegmuller R; Cerami C; Prentice AM
Sci Rep; 2019 Nov; 9(1):16596. PubMed ID: 31719592
[TBL] [Abstract][Full Text] [Related]
18. Erythropoietin's inhibiting impact on hepcidin expression occurs indirectly.
Gammella E; Diaz V; Recalcati S; Buratti P; Samaja M; Dey S; Noguchi CT; Gassmann M; Cairo G
Am J Physiol Regul Integr Comp Physiol; 2015 Feb; 308(4):R330-5. PubMed ID: 25519735
[TBL] [Abstract][Full Text] [Related]
19. Iron deficiency, elevated erythropoietin, fibroblast growth factor 23, and mortality in the general population of the Netherlands: A cohort study.
Eisenga MF; De Jong MA; Van der Meer P; Leaf DE; Huls G; Nolte IM; Gaillard CAJM; Bakker SJL; De Borst MH
PLoS Med; 2019 Jun; 16(6):e1002818. PubMed ID: 31170159
[TBL] [Abstract][Full Text] [Related]
20. Pretreatment with CO-releasing molecules suppresses hepcidin expression during inflammation and endoplasmic reticulum stress through inhibition of the STAT3 and CREBH pathways.
Shin DY; Chung J; Joe Y; Pae HO; Chang KC; Cho GJ; Ryter SW; Chung HT
Blood; 2012 Mar; 119(11):2523-32. PubMed ID: 22262759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
